Translating Evidence and Technology-Based Innovations in Continuous Glucose Monitoring (CGM) to the Front Lines of Clinical Practice

Program Medium

Internet-based program

Estimated Time to Complete Educational Activity

2.0 hours

Course Overview

In this web-based program, physicians will learn how recent developments in continuous glucose monitoring have advanced the management of Type 1 and Type 2 diabetes.

Release Date

June 25, 2019

Expiration Date

June 25, 2021

Method of Physician Participation Utilized in Learning Process

There are no fees for participating and receiving CME credit for this activity. During the period June 25, 2019 to June 25, 2021 participants must:
1) read the learning objectives and faculty disclosures;
2) study the educational activity, and are expected to view all 6 segments totaling 2.0 hours to successfully complete the activity and earn CME credit;
3) register and complete the evaluation form and post-test;
4) score 100% on the post-test; and
5) print out your CME certificate.

Registration

Participation in this WebCAST is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support

Supported by an educational grant from Abbott

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts, Office of Continuing Medical Education, and CMEducation Resources, LLC. The University of Massachusetts, Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physician.

Credit Designation Statement

The University of Massachusetts, Office of Continuing Medical Education  designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure

The University of Massachusetts, Office of Continuing Medical Education  requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to University of Massachusetts, Office of Continuing Medical Education policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Other Credits

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCM.

Program Faculty and Disclosure

Vivian Fonseca, MD – PROGRAM CHAIR

Professor of Medicine and Pharmacology  Tullis Tulane Alumni Chair in Diabetes  Chief, Section of Endocrinology

Tulane University Health Sciences Center  Past President, Science and Medicine  American Diabetes Association

New Orleans, LA, USA

Consulting: Honoraria: Takeda, Novo Nordisk, Sanofi – Aventis, Eli,  Abbott, AstraZeneca, Intarcia, Asahi

Research Support (To Tulane): Grants from Bayer and Boehringer Ingelheim

Stock Options: Microbiome Technologies, Insulin Algorithms,  BRAVO4Health.   

 Stock:  Amgen

Richard Bergenstal, MD

Executive Director

International Diabetes Center- Park Nicollet

Minneapolis, MN, USA

Advisory Board, Research Support and Consulting: Abbott Diabetes Care, DexCom, Eli Lilly, Hygieia, Johnson &  Johnson, Medtronic, Novo Nordisk, Roche, Sanofi. 

Consultant: Onduo, Senseonics and United Healthcare 

James R. Gavin III, MD, PhD

Clinical Professor of Medicine

Emory University School of Medicine  Atlanta, Georgia

Clinical Professor of Medicine

Indiana University School of Medicine  Indianapolis, IN, USA

Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Lilly USA, Janssen  Scientific Affairs, Novo Nordisk, Salix 

Advisory Board and Consulting: Novo Nordisk,  Abbott Diabetes Care 

Ramzi Ajjan, MD, PhD

Associate Professor/Consultant in Diabetes and Endocrinology

University of Leeds and Leeds teaching Hospitals Trust

Leeds, United Kingdom

Consultant and Research Support: Abbott Diabetes Care

Program Manager and Reviewer Disclosure 

Program Manager Gideon Bosker, MD  and Denise Leary have nothing to disclose.

Educational Objectives

Upon completion of this activity, participants will be able to:

• Outline and discuss the evidentiary basis for senor/patch-based CGM technologies, and how to best Implement CGM-based technologies into their overall diabetes care plans for patients with T1D and T2D.
• Analyze the rationale and evidence for recommending and facilitating adoption of technology-centric CGM monitoring and treatment plans using patch-and-reader-based technologies.
• Compare and contrast available CGM-facilitating monitoring technologies and pair such technologies with optimal patient profiles.
• Educate patients with diabetes about the rationale, evidence, and outcome- optimizing results associated with technology-based, patient-centric and physician-directed CGM monitoring strategies that can be used to effect optimal lifestyle, diet-, and pharmacology-based approaches to attaining guideline-based HA1c levels in patients with T1d and T2D.
• Identify which patients with diabetes are ideal candidates for a technology-based, patient-directed glucose monitoring system. 

Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

• We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.

• For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.

• We may use the Information to send you information about other CME activities that CMEducation Resources is offering.

• If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.

• You should check this privacy policy periodically to see whether we have made any changes